Exchange Traded Concepts LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 89.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,897 shares of the healthcare conglomerate's stock after selling 15,435 shares during the period. Exchange Traded Concepts LLC's holdings in UnitedHealth Group were worth $960,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates lifted its position in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares in the last quarter. West Financial Advisors LLC purchased a new stake in UnitedHealth Group in the 3rd quarter worth approximately $32,000. Quarry LP lifted its holdings in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the third quarter worth $37,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Down 0.6 %
UnitedHealth Group stock traded down $3.27 during mid-day trading on Friday, hitting $542.30. The company's stock had a trading volume of 4,120,450 shares, compared to its average volume of 4,209,506. The stock has a market cap of $499.07 billion, a PE ratio of 34.99, a P/E/G ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a 50 day moving average of $536.17 and a 200-day moving average of $565.14.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm earned $5.83 EPS. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.64 EPS for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm's stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.33% of the company's stock.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on UNH. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. Finally, Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $629.32.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
![Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)](https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&Symbol=UNH)
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.